MetaADEDB 2.0 @ LMMD
atovaquone, proguanil drug combination
(QMNFFXRFOJIOKZ-UHFFFAOYSA-N)
Structure
SMILES
Clc1ccc(cc1)N1C(=NC(=NC1(C)C)N)N
Type(s)
Approved
ATC code(s)
P01BB02
Molecular Formula:
C11H14ClN5
Molecular Weight:
251.715
Log P:
1.8623
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
80
CAS Number(s):
516-21-2
Synonym(s)
1.
atovaquone, proguanil drug combination
2.
atovaquone-proguanil
3.
malarone
External Link(s)
MeSHC109496
PubChem Compound9049
BindingDB18792
ChEBI135029
CHEMBLCHEMBL747
DrugBankDB14763
DrugCentral754
IUPHAR/BPS Guide to PHARMACOLOGY10027
Therapeutic Target DatabaseD0O9YG
ZINC1233
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MalariaFAERS: 89
Canada Vigilance: 8
Canada Vigilance
OFFSIDES
US FAERS
2VomitingFAERS: 87
Canada Vigilance: 8
Canada Vigilance
US FAERS
3NauseaFAERS: 77
Canada Vigilance: 5
Canada Vigilance
US FAERS
4MalaiseFAERS: 73
Canada Vigilance: 4
Canada Vigilance
US FAERS
5HeadacheFAERS: 69
Canada Vigilance: 2
Canada Vigilance
US FAERS
6Drug ineffectiveFAERS: 67
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
7DizzinessFAERS: 53
Canada Vigilance: 7
Canada Vigilance
US FAERS
8FatigueFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
9AstheniaFAERS: 48
Canada Vigilance: 4
Canada Vigilance
US FAERS
10AnxietyFAERS: 44
Canada Vigilance: 2
Canada Vigilance
US FAERS
11Abdominal PainFAERS: 35
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
US FAERS
12UrticariaFAERS: 31
Canada Vigilance: 6
Canada Vigilance
US FAERS
13Drug exposure during pregnancyFAERS: 26OFFSIDES
US FAERS
14AlopeciaFAERS: 25
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
15HypersensitivityFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
16ThrombocytopeniaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Pharmaceutical product complaintFAERS: 23OFFSIDES
US FAERS
18PruritusFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
19Weight decreasedFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
20ChillsFAERS: 20US FAERS
21SyncopeFAERS: 20US FAERS
22Gamma-Glutamyltransferase IncreasedFAERS: 17OFFSIDES
US FAERS
23MyalgiaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
24jaundiceFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
25AnorexiaFAERS: 16OFFSIDES
US FAERS
26Aspartate Aminotransferase IncreasedFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
27Transaminases increasedFAERS: 15OFFSIDES
US FAERS
28Alanine Aminotransferase IncreasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
29Chest PainFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
30DehydrationFAERS: 14US FAERS
31Plasmodium falciparum infectionFAERS: 14
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
US FAERS
32ErythemaFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
33AngioedemaFAERS: 12OFFSIDES
US FAERS
34PsoriasisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
35TachycardiaFAERS: 12US FAERS
36CryingFAERS: 11US FAERS
37ParanoiaFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
38StomatitisFAERS: 11US FAERS
39TremorFAERS: 11US FAERS
40Aphthous StomatitisFAERS: 10OFFSIDES
US FAERS
41ChromaturiaFAERS: 10OFFSIDES
US FAERS
42DeliriumFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
43LethargyFAERS: 10US FAERS
44PalpitationsFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
45PancreatitisFAERS: 10
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
46Skin reactionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
47VasculitisFAERS: 10US FAERS
48VertigoFAERS: 10US FAERS
49Abdominal discomfortFAERS: 9
Canada Vigilance: 4
Canada Vigilance
US FAERS
50Chest discomfortFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Dry skinFAERS: 9US FAERS
52HypotensionFAERS: 9US FAERS
53Oropharyngeal painFAERS: 9OFFSIDES
US FAERS
54Rash erythematousFAERS: 9US FAERS
55Skin lesionFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
56TinnitusFAERS: 9US FAERS
57AbasiaFAERS: 8OFFSIDES
US FAERS
58BlindnessFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Feeling abnormalFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
60HepatitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
61NeutropeniaFAERS: 8US FAERS
62PainFAERS: 8OFFSIDES
US FAERS
63Stevens-Johnson SyndromeFAERS: 8
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
64Depressed moodFAERS: 7US FAERS
65LeukopeniaFAERS: 7US FAERS
66OverdoseFAERS: 7US FAERS
67PallorFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
68Product quality issueFAERS: 7US FAERS
69Visual ImpairmentFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Accidental overdoseFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
71Atrial FibrillationFAERS: 6US FAERS
72ConstipationFAERS: 6US FAERS
73Depressed Level of ConsciousnessFAERS: 6US FAERS
74DisorientationFAERS: 6US FAERS
75DissociationFAERS: 6US FAERS
76DysgeusiaFAERS: 6US FAERS
77EczemaFAERS: 6OFFSIDES
US FAERS
78EpistaxisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
79Gastrointestinal PainFAERS: 6US FAERS
80InflammationFAERS: 6US FAERS
81Joint swellingFAERS: 6US FAERS
82Night sweatsFAERS: 6US FAERS
83Pharyngolaryngeal PainFAERS: 6US FAERS
84SomnolenceFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
85SwellingFAERS: 6US FAERS
86Acute psychosisFAERS: 5OFFSIDES
US FAERS
87AgitationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
88AmnesiaFAERS: 5US FAERS
89ArthralgiaFAERS: 5US FAERS
90ArthropathyFAERS: 5OFFSIDES
US FAERS
91Cold sweatFAERS: 5US FAERS
92Completed SuicideFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
93Drug dispensing errorFAERS: 5US FAERS
94EosinophiliaFAERS: 5US FAERS
95EpilepsyFAERS: 5OFFSIDES
US FAERS
96General physical health deteriorationFAERS: 5US FAERS
97HypophagiaFAERS: 5US FAERS
98InfectionFAERS: 5OFFSIDES
US FAERS
99LymphadenopathyFAERS: 5US FAERS
100NervousnessFAERS: 5US FAERS
101PancytopeniaFAERS: 5US FAERS
102PneumoniaFAERS: 5US FAERS
103Poor quality sleepFAERS: 5OFFSIDES
US FAERS
104RestlessnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Therapeutic response unexpectedFAERS: 5OFFSIDES
US FAERS
106Adverse eventFAERS: 4US FAERS
107Anaphylactic shockFAERS: 4US FAERS
108Arthropod biteFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
109Back PainFAERS: 4US FAERS
110Bile Duct StenosisFAERS: 4US FAERS
111Blood alkaline phosphatase increasedFAERS: 4OFFSIDES
US FAERS
112Blood creatine phosphokinase increasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
113BronchitisFAERS: 4US FAERS
114CataractFAERS: 4US FAERS
115CholestasisFAERS: 4US FAERS
116Drug exposure before pregnancyFAERS: 4OFFSIDES
US FAERS
117DyspepsiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Impaired work abilityFAERS: 4US FAERS
119Inappropriate schedule of drug administrationFAERS: 4OFFSIDES
US FAERS
120Maternal exposure before pregnancyFAERS: 4US FAERS
121Oral painFAERS: 4US FAERS
122RhabdomyolysisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
123SomnambulismFAERS: 4US FAERS
124SplenomegalyFAERS: 4US FAERS
125Urinary tract infectionFAERS: 4US FAERS
126Visual disturbanceFAERS: 4US FAERS
127treatment failureFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
128AgranulocytosisFAERS: 3US FAERS
129ApathyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
130AsphyxiaFAERS: 3US FAERS
131Blood albumin decreasedFAERS: 3US FAERS
132Blood amylase increasedFAERS: 3OFFSIDES
US FAERS
133Blood glucose abnormalFAERS: 3OFFSIDES
US FAERS
134Blood sodiumFAERS: 3OFFSIDES
US FAERS
135Burning sensationFAERS: 3US FAERS
136Cerebrovascular accidentFAERS: 3US FAERS
137ClaustrophobiaFAERS: 3OFFSIDES
US FAERS
138ColitisFAERS: 3US FAERS
139Conversion disorderFAERS: 3US FAERS
140Drug administration errorFAERS: 3OFFSIDES
US FAERS
141DysarthriaFAERS: 3US FAERS
142DysuriaFAERS: 3US FAERS
143EcchymosisFAERS: 3US FAERS
144FlatulenceFAERS: 3US FAERS
145Food PoisoningFAERS: 3OFFSIDES
US FAERS
146GastroenteritisFAERS: 3US FAERS
147GlossitisFAERS: 3US FAERS
148Hepatic necrosisFAERS: 3OFFSIDES
US FAERS
149Lipase increasedFAERS: 3US FAERS
150Maternal exposure during pregnancyFAERS: 3US FAERS
151Mental impairmentFAERS: 3US FAERS
152Motion SicknessFAERS: 3US FAERS
153Myoclonic EpilepsyFAERS: 3US FAERS
154NasopharyngitisFAERS: 3US FAERS
155Ocular icterusFAERS: 3US FAERS
156Parasite blood test positiveFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
157Prescribed overdoseFAERS: 3OFFSIDES
US FAERS
158PurpuraFAERS: 3US FAERS
159Retinal Artery OcclusionFAERS: 3OFFSIDES
US FAERS
160Retinal Vein OcclusionFAERS: 3OFFSIDES
US FAERS
161SchizophreniaFAERS: 3OFFSIDES
US FAERS
162Sleep TalkingFAERS: 3OFFSIDES
US FAERS
163Toxic Epidermal NecrolysisFAERS: 3US FAERS
164Visual acuity reduced transientlyFAERS: 3OFFSIDES
US FAERS
165Water IntoxicationFAERS: 3OFFSIDES
US FAERS
166Acute kidney injuryFAERS: 2US FAERS
167AngerFAERS: 2US FAERS
168AphasiaFAERS: 2US FAERS
169AsthenopiaFAERS: 2US FAERS
170AsthmaFAERS: 2US FAERS
171Autoimmune hepatitisFAERS: 2OFFSIDES
US FAERS
172Blood creatinine increasedFAERS: 2US FAERS
173Blood glucose increasedFAERS: 2US FAERS
174Blood urea increasedFAERS: 2US FAERS
175BronchopneumoniaFAERS: 2US FAERS
176Clostridium difficile colitisFAERS: 2US FAERS
177Cytomegalovirus test positiveFAERS: 2US FAERS
178DeafnessFAERS: 2US FAERS
179DemyelinationFAERS: 2US FAERS
180Dengue FeverFAERS: 2US FAERS
181Depression suicidalFAERS: 2US FAERS
182DiplopiaFAERS: 2OFFSIDES
US FAERS
183DiscomfortFAERS: 2US FAERS
184Drug administered to patient of inappropriate ageFAERS: 2US FAERS
185DysphoniaFAERS: 2OFFSIDES
US FAERS
186Flight of ideasFAERS: 2US FAERS
187FormicationFAERS: 2US FAERS
188Genital swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
189GingivitisFAERS: 2US FAERS
190HepatosplenomegalyFAERS: 2US FAERS
191HypomaniaFAERS: 2US FAERS
192Incision site abscessFAERS: 2OFFSIDES
US FAERS
193Incorrect dose administeredFAERS: 2US FAERS
194InfluenzaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
195Lichen PlanusFAERS: 2US FAERS
196LymphomaFAERS: 2US FAERS
197LymphopeniaFAERS: 2US FAERS
198MeningoceleFAERS: 2OFFSIDES
US FAERS
199Musculoskeletal stiffnessFAERS: 2US FAERS
200NecrosisFAERS: 2US FAERS
201NeuralgiaFAERS: 2US FAERS
202Ocular vascular disorderFAERS: 2US FAERS
203Oral infectionFAERS: 2OFFSIDES
US FAERS
204PericarditisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
205PetechiaeFAERS: 2US FAERS
206PharyngitisFAERS: 2US FAERS
207PhotophobiaFAERS: 2US FAERS
208PityriasisFAERS: 2OFFSIDES
US FAERS
209PolydactylyFAERS: 2US FAERS
210Pre-existing condition improvedFAERS: 2US FAERS
211PresyncopeFAERS: 2US FAERS
212Product use issueFAERS: 2US FAERS
213Prothrombin level abnormalFAERS: 2US FAERS
214PrurigoFAERS: 2US FAERS
215Pulmonary EmbolismFAERS: 2US FAERS
216Renal AdenomaFAERS: 2US FAERS
217Respiratory arrestFAERS: 2US FAERS
218RetchingFAERS: 2US FAERS
219Retinal DetachmentFAERS: 2US FAERS
220Splenic RuptureFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
221Suicide attemptFAERS: 2US FAERS
222SunburnFAERS: 2US FAERS
223TYPHUSFAERS: 2OFFSIDES
US FAERS
224ThrombophlebitisFAERS: 2US FAERS
225UveitisFAERS: 2US FAERS
226VIIth nerve paralysisFAERS: 2US FAERS
227White blood cell count decreasedFAERS: 2US FAERS
228Abdominal tendernessFAERS: 1US FAERS
229Abnormal sleep-related eventFAERS: 1US FAERS
230AbscessFAERS: 1US FAERS
231Accidental underdoseFAERS: 1US FAERS
232AcneFAERS: 1US FAERS
233Acute respiratory failureFAERS: 1US FAERS
234AgeusiaFAERS: 1US FAERS
235AkathisiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Alopecia AreataFAERS: 1US FAERS
237Alopecia effluviumFAERS: 1US FAERS
238Altered state of consciousnessFAERS: 1US FAERS
239Anorexia NervosaFAERS: 1US FAERS
240AtaxiaFAERS: 1US FAERS
241AtherosclerosisFAERS: 1US FAERS
242Auricular swellingFAERS: 1US FAERS
243Autoimmune thrombocytopeniaFAERS: 1US FAERS
244BedriddenFAERS: 1OFFSIDES
US FAERS
245Bilirubin conjugated increasedFAERS: 1OFFSIDES
US FAERS
246Blood cholinesterase increasedFAERS: 1US FAERS
247Blood creatinine abnormalFAERS: 1US FAERS
248Blood immunoglobulin E increasedFAERS: 1US FAERS
249Blood lactate dehydrogenase abnormalFAERS: 1US FAERS
250Blood lactate dehydrogenase increasedFAERS: 1US FAERS
251Blood sodium decreasedFAERS: 1US FAERS
252Blood urea abnormalFAERS: 1US FAERS
253Bulimia NervosaFAERS: 1US FAERS
254Carcinoembryonic antigen increasedFAERS: 1US FAERS
255Cardiac discomfortFAERS: 1US FAERS
256Cataract operationFAERS: 1US FAERS
257Cerebral InfarctionFAERS: 1US FAERS
258Choking sensationFAERS: 1US FAERS
259ChorioretinitisFAERS: 1US FAERS
260ClubbingFAERS: 1OFFSIDES
US FAERS
261Congenital HypothyroidismFAERS: 1US FAERS
262Congenital hearing disorderFAERS: 1US FAERS
263Congenital hydronephrosisFAERS: 1US FAERS
264ConjunctivitisFAERS: 1US FAERS
265CystitisFAERS: 1US FAERS
266Cytolytic hepatitisFAERS: 1US FAERS
267Delusion of referenceFAERS: 1OFFSIDES
US FAERS
268Delusional disorder, jealous typeFAERS: 1US FAERS
269Delusional disorder, persecutory typeFAERS: 1US FAERS
270DementiaFAERS: 1US FAERS
271Disseminated Intravascular CoagulationFAERS: 1US FAERS
272Drug dose omissionFAERS: 1US FAERS
273Drug resistanceFAERS: 1US FAERS
274Drug therapeutic incompatibilityFAERS: 1US FAERS
275DysenteryFAERS: 1US FAERS
276Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
277Electroencephalogram abnormalFAERS: 1US FAERS
278Electrolyte depletionFAERS: 1US FAERS
279Electrolyte imbalanceFAERS: 1US FAERS
280Emergency care examinationFAERS: 1US FAERS
281Emotional disorderFAERS: 1US FAERS
282Emotional distressFAERS: 1US FAERS
283EnteritisFAERS: 1US FAERS
284Enzyme abnormalityFAERS: 1US FAERS
285Erectile dysfunctionFAERS: 1US FAERS
286Erythema MultiformeFAERS: 1OFFSIDES
US FAERS
287Euphoric moodFAERS: 1US FAERS
288Expired drug administeredFAERS: 1US FAERS
289Expired product administeredFAERS: 1US FAERS
290Extra dose administeredFAERS: 1US FAERS
291Eye painFAERS: 1US FAERS
292Eyelid exfoliationFAERS: 1US FAERS
293Eyelids pruritusFAERS: 1US FAERS
294Feeling jitteryFAERS: 1US FAERS
295Feeling of body temperature changeFAERS: 1US FAERS
296Foreign travelFAERS: 1US FAERS
297Full blood count decreasedFAERS: 1OFFSIDES
US FAERS
298Gastric ulcerFAERS: 1US FAERS
299GastritisFAERS: 1US FAERS
300Gastrointestinal inflammationFAERS: 1US FAERS
301GastroschisisFAERS: 1US FAERS
302General symptomFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Guttate psoriasisFAERS: 1OFFSIDES
US FAERS
304Head discomfortFAERS: 1US FAERS
305HemiparesisFAERS: 1US FAERS
306HepatotoxicityFAERS: 1US FAERS
307Hip DysplasiaFAERS: 1US FAERS
308HypersomniaFAERS: 1US FAERS
309HypertransaminasaemiaFAERS: 1US FAERS
310HyperventilationFAERS: 1US FAERS
311HypervigilanceFAERS: 1US FAERS
312HypochondriasisFAERS: 1US FAERS
313HypokinesiaFAERS: 1US FAERS
314HypoxiaFAERS: 1US FAERS
315ImmobileFAERS: 1US FAERS
316Immune Reconstitution Inflammatory SyndromeFAERS: 1US FAERS
317Impaired driving abilityFAERS: 1US FAERS
318Impaired self-careFAERS: 1US FAERS
319IncoherentFAERS: 1US FAERS
320Inflammatory marker increasedFAERS: 1US FAERS
321Intentional self-injuryFAERS: 1US FAERS
322Intercepted drug prescribing errorFAERS: 1US FAERS
323Intestinal mucosal hypertrophyFAERS: 1US FAERS
324Irritable Bowel SyndromeFAERS: 1US FAERS
325Joint Range of Motion DecreasedFAERS: 1US FAERS
326Laboratory test interferenceFAERS: 1US FAERS
327LeukocytosisFAERS: 1US FAERS
328Ligament injuryFAERS: 1US FAERS
329Limb injuryFAERS: 1US FAERS
330Lip swellingFAERS: 1US FAERS
331Lipase abnormalFAERS: 1US FAERS
332Loss of personal independence in daily activitiesFAERS: 1US FAERS
333Lymphocyte count decreasedFAERS: 1US FAERS
334MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
335Malaria antibody test positiveFAERS: 1US FAERS
336MalnutritionFAERS: 1US FAERS
337Memory impairmentFAERS: 1US FAERS
338Middle insomniaFAERS: 1US FAERS
339Mood swingsFAERS: 1US FAERS
340Muscle CrampFAERS: 1US FAERS
341MutismFAERS: 1US FAERS
342MyelofibrosisFAERS: 1US FAERS
343MyopiaFAERS: 1US FAERS
344NarcolepsyFAERS: 1US FAERS
345Neck PainFAERS: 1US FAERS
346Nerve injuryFAERS: 1US FAERS
347Neutrophil count decreasedFAERS: 1US FAERS
348Nonspecific reactionFAERS: 1US FAERS
349NystagmusFAERS: 1US FAERS
350Obsessive thoughtsFAERS: 1US FAERS
351Oculomucocutaneous syndromeFAERS: 1US FAERS
352OligodipsiaFAERS: 1OFFSIDES
US FAERS
353Optic NeuritisFAERS: 1OFFSIDES
US FAERS
354Oral mucosal exfoliationFAERS: 1OFFSIDES
US FAERS
355Oropharyngeal blisteringFAERS: 1OFFSIDES
US FAERS
356OtotoxicityFAERS: 1US FAERS
357Panic DisorderFAERS: 1US FAERS
358Parasitic gastroenteritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
359Patient uncooperativeFAERS: 1US FAERS
360Personality ChangeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
361Plasmodium vivax infectionFAERS: 1US FAERS
362Pleuritic painFAERS: 1US FAERS
363PolyneuropathyFAERS: 1US FAERS
364Product administered to patient of inappropriate ageFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
365Product complaintFAERS: 1US FAERS
366Product dose omissionFAERS: 1US FAERS
367Product physical consistency issueFAERS: 1US FAERS
368Product preparation errorFAERS: 1US FAERS
369Product storage errorFAERS: 1US FAERS
370Product taste abnormalFAERS: 1US FAERS
371Psychiatric decompensationFAERS: 1US FAERS
372Psychiatric symptomFAERS: 1US FAERS
373Pulmonary vasculitisFAERS: 1US FAERS
374RalesFAERS: 1US FAERS
375Respiratory FailureFAERS: 1US FAERS
376Respiratory distressFAERS: 1US FAERS
377Reticulocyte count decreasedFAERS: 1OFFSIDES
US FAERS
378ReticulocytosisFAERS: 1OFFSIDES
US FAERS
379Retinal DegenerationFAERS: 1US FAERS
380ScabFAERS: 1US FAERS
381ScreamingFAERS: 1US FAERS
382Sinus ArrhythmiaFAERS: 1US FAERS
383Sinus TachycardiaFAERS: 1US FAERS
384Skin UlcerFAERS: 1US FAERS
385Skin irritationFAERS: 1US FAERS
386Skin necrosisFAERS: 1US FAERS
387Somatoform DisorderFAERS: 1US FAERS
388SoporFAERS: 1US FAERS
389Spleen palpableFAERS: 1US FAERS
390StarvationFAERS: 1US FAERS
391StressFAERS: 1US FAERS
392Superinfection fungalFAERS: 1US FAERS
393Supraventricular tachyarrhythmiaFAERS: 1US FAERS
394Suspected counterfeit productFAERS: 1US FAERS
395TetanyFAERS: 1US FAERS
396Therapy non-responderFAERS: 1US FAERS
397Thrombocytopenic purpuraFAERS: 1US FAERS
398ThrombocytosisFAERS: 1US FAERS
399ThrombosisFAERS: 1US FAERS
400Tongue bitingFAERS: 1US FAERS
401Tongue discomfortFAERS: 1US FAERS
402Trisomy 21FAERS: 1US FAERS
403Unevaluable eventFAERS: 1US FAERS
404UrethritisFAERS: 1US FAERS
405Vasculitic rashFAERS: 1OFFSIDES
US FAERS
406Vital functions abnormalFAERS: 1US FAERS
407Vitreous floatersFAERS: 1US FAERS
408WheezingFAERS: 1US FAERS
409Wrong doseFAERS: 1US FAERS
410XanthopsiaFAERS: 1US FAERS
411furuncleFAERS: 1OFFSIDES
US FAERS
412nervous system disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
413Abnormal visionOFFSIDES
414Amylase increasedCanada Vigilance: 1Canada Vigilance
415Bacterial sepsisOFFSIDES
416Blighted ovumOFFSIDES
417Blood blisterOFFSIDES
418Blood immunoglobulin EOFFSIDES
419Blood iron decreasedOFFSIDES
420Bone marrow toxicityOFFSIDES
421Conjunctival depositOFFSIDES
422Creatinine renal clearance increasedOFFSIDES
423Diabetes InsipidusOFFSIDES
424DiarrheaOFFSIDES
425Eye inflammationOFFSIDES
426Fatty LiverOFFSIDES
427Feeling ColdOFFSIDES
428Gait inabilityCanada Vigilance: 1Canada Vigilance
429Gastrointestinal sounds abnormalOFFSIDES
430GlaucomaOFFSIDES
431Glycogen Storage Disease Type IOFFSIDES
432GoutOFFSIDES
433Hay feverOFFSIDES
434HypermetabolismOFFSIDES
435ImpatienceOFFSIDES
436Intraocular inflammationOFFSIDES
437LeukoencephalopathyOFFSIDES
438LipaseOFFSIDES
439Lung consolidationOFFSIDES
440Lyme DiseaseOFFSIDES
441Muscle WeaknessOFFSIDES
442Muscle tightnessOFFSIDES
443Myeloid maturation arrestOFFSIDES
444Nasal discomfortOFFSIDES
445Oropharyngeal swellingCanada Vigilance: 1Canada Vigilance
446PROTHROMBIN TIMEOFFSIDES
447Pericardial effusionCanada Vigilance: 1Canada Vigilance
448Peripheral swellingCanada Vigilance: 1Canada Vigilance
449PneumothoraxOFFSIDES
450PolymenorrheaOFFSIDES
451PolyuriaOFFSIDES
452Product dispensing errorCanada Vigilance: 2Canada Vigilance
453Prothrombin time ratioOFFSIDES
454Psychiatric evaluationCanada Vigilance: 1Canada Vigilance
455Rectal tenesmusOFFSIDES
456Serum SicknessOFFSIDES
457Sudden onset of sleepOFFSIDES
458Supraventricular tachycardiaOFFSIDES
459Wheelchair userCanada Vigilance: 1Canada Vigilance
460Wound necrosisOFFSIDES
461bone marrow fibrosisOFFSIDES
462effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.